A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsSreenath V. Sharma, Jeff Settleman, Diana Lee et al.|Cell|2010Cited by 2.8k
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancersJeffrey A. Engelman, Kwok‐Kin Wong, Liang Chen et al.|Nature Medicine|2008Cited by 1.3k
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras OncogeneJi Luo, Stephen J. Elledge, Michael J. Emanuele et al.|Cell|2009Cited by 1k
High-throughput oncogene mutation profiling in human cancerRoman K. Thomas, Meenhard Herlyn, Alissa C. Baker et al.|Nature Genetics|2007Cited by 996
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsDiana Miao, Eliezer M. Van Allen, Claire A. Margolis et al.|Nature Genetics|2018Cited by 701